Smith Jeffrey T L
SEC CIK 1604800 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ZYME | Zymeworks Inc. | EVP, Chief Medical Off | 36.0K | — | $641.3K | 6 | 2025-01-06 | 2026-01-12 |
Most active insiders at ZYME, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Galbraith Kenneth | COB, CEO, Dir | — | $3.34M |
| 2 | Moore Paul Andrew | CSO | — | $721.5K |
| 3 | Smith Jeffrey T L | EVP, Chief Medical Off | — | $475.6K |
| 4 | Hollywood Mark | EVP, COO | — | $138.7K |
| 5 | PATTERSON LEONE D | EVP, Chief Bus, Fin Off | — | — |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-12 | 2026-01-12 | ZYME | Zymeworks Inc. | Smith Jeffrey T L | EVP, Chief Medical Off | M - OptEx | $0.00 | +17.7K | 36.0K | +96% | $0 |
| D | 2026-01-12 | 2026-01-12 | ZYME | Zymeworks Inc. | Smith Jeffrey T L | EVP, Chief Medical Off | S - Sale+OE | $22.67 | -9,310 | 26.7K | -26% | -$211.1K |
| D | 2026-01-05 | 2026-01-05 | ZYME | Zymeworks Inc. | Smith Jeffrey T L | EVP, Chief Medical Off | M - OptEx | $0.00 | +20.0K | 28.9K | +225% | $0 |
| D | 2026-01-05 | 2026-01-05 | ZYME | Zymeworks Inc. | Smith Jeffrey T L | EVP, Chief Medical Off | S - Sale+OE | $25.10 | -10.5K | 18.4K | -36% | -$264.5K |
| D | 2025-01-06 | 2025-01-06 | ZYME | Zymeworks Inc. | Smith Jeffrey T L | EVP, Chief Medical Off | M - OptEx | $0.00 | +20.0K | 20.0K | New | $0 |
| D | 2025-01-06 | 2025-01-06 | ZYME | Zymeworks Inc. | Smith Jeffrey T L | EVP, Chief Medical Off | S - Sale+OE | $14.92 | -11.1K | 8,890 | -56% | -$165.8K |
Purchase Sale Sale after option exercise All abbreviations